Insider Buying: Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Dire

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) Director Johan Wedell-Wedellsborg purchased 62,516 shares of the stock in a transaction that occurred on Monday, November 27th. The shares were purchased at an average price of $5.49 per share, with a total value of $343,212.84. Following the completion of the acquisition, the director now directly owns […]

Related Keywords

United States , Johan Wedell Wedellsborg , Rice Hall James Associates , Morgan Stanley , Nasdaq , Victory Capital Management Inc , Avestar Capital , Acadian Asset Management , Y Mabs Therapeutics Inc , Jpmorgan Chase Co , Connor Clark Lunn Investment Management Ltd , Y Mabs Therapeutics , Get Free Report , Director Johan Wedell Wedellsborg , Abs Therapeutics , Asset Management , Lunn Investment Management , Hall James , Victory Capital Management , Y Mabs Therapeutics Daily , Nasdaq Ymab , Kymab , Medical , Insider Trading , Nsider Trades , Stocks ,